| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.28 | 6e-07 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-06 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |